| Secondary |
| Drug Use For Unknown Indication |
23.0% |
| Asthma |
16.2% |
| Hiv Infection |
12.2% |
| Crohn's Disease |
6.8% |
| Rheumatoid Arthritis |
6.8% |
| Sciatica |
5.4% |
| Blood Triglycerides Increased |
4.1% |
| Colitis Ulcerative |
4.1% |
| Bronchitis |
2.7% |
| Chronic Obstructive Pulmonary Disease |
2.7% |
| Hypersensitivity |
2.7% |
| Pain |
2.7% |
| Psoriasis |
2.7% |
| Acute Febrile Neutrophilic Dermatosis |
1.4% |
| Ill-defined Disorder |
1.4% |
| Product Used For Unknown Indication |
1.4% |
| Psoriatic Arthropathy |
1.4% |
| Rhinitis |
1.4% |
| Rhinitis Allergic |
1.4% |
|
| Osteonecrosis |
27.3% |
| Sepsis |
13.6% |
| Hyperadrenocorticism |
9.1% |
| Reversible Posterior Leukoencephalopathy Syndrome |
9.1% |
| Disseminated Tuberculosis |
4.5% |
| Furuncle |
4.5% |
| Gastrointestinal Haemorrhage |
4.5% |
| Pyrexia |
4.5% |
| Throat Irritation |
4.5% |
| Transaminases Increased |
4.5% |
| Tuberculosis |
4.5% |
| Tuberculous Tenosynovitis |
4.5% |
| Visual Acuity Reduced |
4.5% |
|
| Concomitant |
| Drug Use For Unknown Indication |
23.1% |
| Crohn's Disease |
15.8% |
| Rheumatoid Arthritis |
15.4% |
| Product Used For Unknown Indication |
8.0% |
| Asthma |
6.1% |
| Premedication |
5.0% |
| Psoriasis |
4.4% |
| Colitis Ulcerative |
3.4% |
| Hypertension |
2.6% |
| Emphysema |
2.4% |
| Prophylaxis |
2.3% |
| Multiple Myeloma |
2.0% |
| Haemoptysis |
1.5% |
| Sinusitis |
1.4% |
| Ankylosing Spondylitis |
1.1% |
| B-cell Lymphoma |
1.1% |
| Dermatitis Exfoliative |
1.1% |
| Epilepsy |
1.1% |
| Multiple Sclerosis |
1.1% |
| Psoriatic Arthropathy |
1.1% |
|
| Hepatosplenic T-cell Lymphoma |
9.2% |
| Pyrexia |
8.2% |
| Weight Decreased |
8.2% |
| Thrombocytopenia |
7.1% |
| Dyspnoea |
6.1% |
| Transaminases Increased |
6.1% |
| Vomiting |
6.1% |
| Urinary Tract Infection |
5.1% |
| Myasthenic Syndrome |
4.1% |
| Osteonecrosis |
4.1% |
| Psoriasis |
4.1% |
| Squamous Cell Carcinoma |
4.1% |
| Staphylococcal Infection |
4.1% |
| Traumatic Haematoma |
4.1% |
| Ventricular Fibrillation |
4.1% |
| Breast Cancer |
3.1% |
| Infusion Related Reaction |
3.1% |
| Pancytopenia |
3.1% |
| Pharyngitis Streptococcal |
3.1% |
| Pruritus |
3.1% |
|
| Interacting |
| Hiv Infection |
66.7% |
| Bronchitis |
33.3% |
|
| Cushing's Syndrome |
100.0% |
|
